ABOUT US
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
PRODUCTS
NGS Assays Real-time PCR Assays FISH Assays Extraction
GLOBAL BUSINESS
Distributorship
SUPPORT
Customer Service
FAQs
DOWNLOAD
MEET US
MEET US
language
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
Log in
Log in
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
ABOUT US PRODUCTS GLOBAL BUSINESS SUPPORT MEET US
News & Events
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
Visit AmoyDx at AMP Annual Meeting 2018 in USA
Date：2018-11-02Source: AmoyDx
AmoyDx Exhibits in AMP Annual Meeting 2018 (1-3 November, San Antonio, USA) and shows a novel and accurate approach for simultaneous detection of multiple driver gene mutations in NSCLC. Welcome to visit us at Booth 1628 and have deep insight solution for the Multiple Gene Mutations Testing.




 

For more information, please call us at +86-592-6806835 or email us at info@amoydx.com.



Tel：+86-592-6806835
Email：info@amoydx.com
Previous Next
BACK
Recommend
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
27 /03
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
24 /03
Career Opportunities - Business Manager (EMEA)
25 /11
Career Opportunities - The Field Application Scientist
25 /11
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for LUMAKRAS® (Sotorasib)
17 /11
TOP
Inquiry
* Required information
Refresh the image
send
Manage your account info
  • Please Select
  • Mr.
  • Ms.
  • Dr.
  • Prof.
Submit
Change your password
Confirm Submission